Drug Profile
Ferumoxtran-10 dextran-coated
Alternative Names: AMI 227; AMI 227CN; AMI 27; BMS 180549; Combidex; G 53425; SineremLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Advanced Magnetics
- Developer AMAG Pharmaceuticals; Guerbet
- Class Contrast media; Ferric compounds; Glucans; Oxides
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lymphoma
Most Recent Events
- 16 Nov 2020 AMAG Pharmaceuticals has been acquired by Covis Pharma
- 25 Jul 2007 Advanced Magnetics is now called AMAG Pharmaceuticals
- 28 Feb 2007 Advanced Magnetics and Cytogen agreed to early termination of their licensing agreement, and reached a lawsuit settlement